Showing results (161-170 of 1,277) with videos related to
Sort By:
Pageof 128
Immunology and Allergy Clinics of North America|November 25, 2010
Biobehavioral influences on cancer progressionErin S Costanzo, Anil K Sood, Susan K LutgendorfGynecologic Oncology|March 27, 2001
Recurrent carcinoma in situ of a neovaginaM P Lowe, K A Ault, A K SoodJournal of Clinical Microbiology|March 1, 1997
Temporal study of immunoglobin M seroreactivity to Borrelia burgdorferi in patients treated for Lyme borreliosisE Hilton, A Tramontano, J DeVoti, et al.Nature Clinical Practice. Oncology|February 13, 2008
Angiogenesis as a strategic target for ovarian cancer therapyWhitney A Spannuth, Anil K Sood, Robert L ColemanCell Cycle (Georgetown, Tex.)|February 22, 2007
The neuroendocrine impact of chronic stress on cancerPremal H Thaker, Susan K Lutgendorf, Anil K SoodPlant Physiology|November 1, 1984
Metabolism of Monoterpenes : Early Steps in the Metabolism of d-Neomenthyl-beta-d-Glucoside in Peppermint (Mentha piperita) RhizomesR Croteau, V K Sood, B Renstrøm, et al.Expert Opinion on Biological Therapy|November 30, 2012
Contemporary use of bevacizumab in ovarian cancerTakahito M Miyake, Anil K Sood, Robert L ColemanCancer Research|February 25, 2010
The dicey role of Dicer: implications for RNAi therapyWilliam M Merritt, Menashe Bar-Eli, Anil K SoodExpert Opinion on Biological Therapy|January 23, 2010
Farletuzumab in epithelial ovarian carcinomaWhitney A Spannuth, Anil K Sood, Robert L ColemanAmerican Journal of Obstetrics and Gynecology|April 4, 2007
Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish woman with primary breast and ovarian cancerWhitney A Spannuth, Premal H Thaker, Anil K SoodPageof 128